A randomized controlled trial of equivalence between pantoprazole and esomeprazole that does not have the power to conclude

J Clin Gastroenterol. 2005 Feb;39(2):172; author reply 172-3.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents / pharmacokinetics*
  • Anti-Ulcer Agents / therapeutic use
  • Benzimidazoles / pharmacokinetics*
  • Benzimidazoles / therapeutic use
  • Esomeprazole / analogs & derivatives*
  • Esomeprazole / pharmacokinetics*
  • Esomeprazole / therapeutic use
  • Gastroesophageal Reflux / drug therapy
  • Gastroesophageal Reflux / metabolism*
  • Humans
  • Pantoprazole
  • Randomized Controlled Trials as Topic
  • Sulfoxides / pharmacokinetics*
  • Sulfoxides / therapeutic use
  • Therapeutic Equivalency
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Sulfoxides
  • Pantoprazole
  • Esomeprazole